已收盘 11-13 16:00:00 美东时间
+0.260
+1.70%
今日重点评级关注:Canaccord Genuity:维持Wave Life Sciences"买入"评级,目标价从42美元升至44美元;Canaccord Genuity:维持Pharming Group"买入"评级,目标价从38美元升至41美元
10-30 12:30
Piper Sandler analyst Crispin Love maintains Happen (NASDAQ:HAPN) with a Overweight and lowers the price target from $25 to $20.
10-29 21:57
Happen (NASDAQ:HAPN) is looking for Q4 GAAP EPS of $0.43-$0.48 vs $0.45 analyst estimate..
10-29 04:13
Happen (NASDAQ:HAPN) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.46 by 8.7 percent. This is a 35.14 percent increase over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $263.200 million which miss...
10-29 04:09
阿波罗全球管理首席经济学家托尔斯滕·斯洛克(Torsten Slok)表示,如果消费者开始高度依赖Meta(META.US)旗下的Muse等人工智能(AI)助手...
09-29 08:12
阿波罗全球管理首席经济学家Torsten Slok表示,如果消费者开始高度依赖通过Muse等人工智能助手把现金自动转入收益率更高的账户,可能会给金融体系带来...
09-29 03:23
今日重点评级关注:HC Wainwright & Co.:维持Q32 Bio"买入"评级,目标价从13美元升至36美元;Chardan Capital:维持ProMIS Neurosciences"买入"评级,目标价从20美元升至33美元
07-29 11:37
BTIG analyst Vincent Caintic reiterates Happen (NASDAQ:HAPN) with a Buy and maintains $25 price target.
07-28 17:53
Happen (NASDAQ:HAPN) is looking for FY2026 GAAP EPS of $1.80-$1.90 vs $1.74 analyst estimate..
07-28 04:38
今日重点评级关注:Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元;康托·菲茨杰拉德:维持BioCryst制药"超配"评级,目标价从27美元升至29美元
07-01 10:40